|
|
|
Corporate Profile: Targeted
Genetics
| Summary: |
Targeted Genetics
Corporation is at the forefront of the rapidly advancing
field of gene therapy, initially developing products
for the treatment of cystic fibrosis, cancer and infectious
diseases. |
| Address:
|
1100 Olive Way
Suite 100
Seattle, WA 98101 |
| Phone
#'s: |
Main |
(206) 623-7612 |
| Human Resources |
(206) 521-7300 |
| Investor Relations |
(206) 623-7612 |
| Fax
#'s: |
Main |
(206) 223-0288 |
| Human Resources |
(206) 521-4782 |
| Investor Relations |
not known |
| Financial
information: |
| TGEN |
| Issued United States patents: |
U.S. patents 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
